STING agonist treatment increases response to chemotherapy and immune checkpoint blockade therapy in a syngeneic murine model of high-grade serous ovarian cancer

被引：0
|
作者：
Ghaffari, Abdi [1 ]
Peterson, Nichole [1 ]
Khalaj, Kasra [1 ]
Robinson, Andrew [2 ]
Francis, Julie-Ann [2 ]
Koti, Madhuri [1 ]
机构：
[1] Queens Univ, Kingston, ON, Canada
[2] Kingston Hlth Sci Ctr, Kingston, ON, Canada
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2017年 / 5卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P277
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Response to treatment and prognostic significance of supradiaphragmatic disease in patients with high-grade serous ovarian cancer
    Maggiore, U. Leone Roberti
    Bogani, G.
    Martinelli, F.
    Signorelli, M.
    Chiappa, V.
    Lopez, S.
    Granato, V.
    Ditto, A.
    Raspagliesi, F.
    EJSO, 2022, 48 (12): : 2551 - 2557
  • [42] Neoadjuvant treatment as a window to chemotherapy driven alterations to the genome and transcriptome of high-grade serous ovarian cancer
    Javellana, Melissa
    Eckert, Mark
    Stock, Elizabeth
    Chapel, David
    Lastra, Ricardo
    Lengyel, Ernst
    GYNECOLOGIC ONCOLOGY, 2021, 162 : S210 - S210
  • [43] A new spontaneously transformed syngeneic model of high-grade serous ovarian cancer with a tumor-initiating cell population
    McCloskey, Curtis W.
    Goldberg, Reuben L.
    Carter, Lauren E.
    Gamwell, Lisa F.
    Al-Hujaily, Ensaf M.
    Colline, Olga
    Macdonald, Elizabeth A.
    Garson, Kenneth
    Daneshmand, Manijeh
    Carmona, Euridice
    Vanderhyden, Barbara C.
    FRONTIERS IN ONCOLOGY, 2014, 4
  • [44] Unlocking the potential of organopalladium complexes for high-grade serous ovarian cancer therapy
    Scattolin, Thomas
    Cavarzerani, Enrico
    Alessi, Dario
    Mauceri, Matteo
    Botter, Eleonora
    Tonon, Giovanni
    Caligiuri, Isabella
    Repetto, Ombretta
    Kamensek, Urska
    Brezar, Simona Kranjc
    Dalla Pozza, Maria
    Palazzolo, Stefano
    Cemazar, Maja
    Canzonieri, Vincenzo
    Demitri, Nicola
    Nolan, Steven P.
    Gasser, Gilles
    Visentin, Fabiano
    Rizzolio, Flavio
    DALTON TRANSACTIONS, 2025, 54 (11) : 4685 - 4696
  • [45] High-grade serous ovarian cancer subtyping identifies pathways for targeted therapy
    Huhtinen, K.
    Chen, P.
    Mikkonen, P.
    Kaipio, K.
    Aittomaki, V.
    Lindell, R.
    Auranen, A.
    Lehtonen, R.
    Hautaniemi, S.
    Carpen, O.
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S157 - S157
  • [46] Biology-driven therapy advances in high-grade serous ovarian cancer
    Wang, Yinu
    Duval, Alexander James
    Adli, Mazhar
    Matei, Daniela
    JOURNAL OF CLINICAL INVESTIGATION, 2024, 134 (01):
  • [47] Molecular analysis of exceptional response in high-grade serous ovarian cancer.
    Garsed, Dale
    Pandey, Ahwan
    Fereday, Sian
    Alsop, Kathryn
    Wouters, Maartje
    Saner, Flurina
    Kennedy, Catherine
    Pearce, Celeste
    Pike, Malcolm
    Ramus, Susan
    Kobel, Martin
    deFazio, Anna
    Goode, Ellen
    Nelson, Brad
    Bowtell, David
    CLINICAL CANCER RESEARCH, 2020, 26 (13) : 17 - 18
  • [48] Chemotherapy response score no longer predicts survival outcomes in high-grade serous ovarian cancer patients with BRCA mutation and/or maintenance therapy
    Lee, Young Joo
    Shin, Yoon Kyung
    Kim, Nae Ry
    Kim, Se Ik
    Lee, Yoo-Young
    Park, Jeong-Yeol
    Kim, Jae-Weon
    Cho, Hyun-Woong
    Lee, Jung-Yun
    JOURNAL OF GYNECOLOGIC ONCOLOGY, 2024, 35 (06)
  • [49] Germline BRCA1/2 status and chemotherapy response score in high-grade serous ovarian cancer
    Morgan, Robert D.
    Wang, Xin
    Barnes, Bethany M.
    Spurgeon, Laura
    Carrot, Aurore
    Netto, Daniel
    Hasan, Jurjees
    Mitchell, Claire
    Salih, Zena
    Desai, Sudha
    Shaw, Joseph
    Winter-Roach, Brett
    Schlecht, Helene
    Burghel, George J.
    Clamp, Andrew R.
    Edmondson, Richard J.
    You, Benoit
    Evans, D. Gareth R.
    Jayson, Gordon C.
    Taylor, Stephen S.
    BRITISH JOURNAL OF CANCER, 2024, 131 (12) : 1919 - 1927
  • [50] Focal adhesion kinase inhibitors as maintenance therapy in a homologous recombination repair proficient high-grade serous ovarian cancer murine model
    Hill, Breana
    Bondre, Ioana
    Tahon, Elise
    Soylu, Halime Meryem
    Chen, Xiao Lei
    Ojalill, Marjaana
    Zhang, Joanna
    Hom-Tedla, Marianne
    Wilson, Elise
    Saenz, Cheryl
    Plaxe, Steven
    Eskander, Ramez
    Binder, Pratibha
    McHale, Michael
    Schlaepfer, David
    Stupack, Dwayne
    GYNECOLOGIC ONCOLOGY, 2024, 190 : S93 - S94
12345